TECHNOLOGY FOR THE DETERMINATION OF MINOR FRACTIONS OF MODIFIED LIPOPROTEINS-α IN CORONARY ATHEROSCLEROSIS

DOI: https://doi.org/10.29296/24999490-2020-01-05

N.V. Kanskaya(1), А.N. Baikov(1), V.V. Udut(2), N.A. Fedorova(3), D.A. Kudlay(4), I.A. Pozdniakova(1), I.G. Samoilova(1), O.A. Oleynik(1), E.V. Udut(1), N.S. Denisov(1), D.A. Dyakov(1), E.Y. Medinceva(1), V.E. Skurihina(1), 1-Siberian State Medical University, Moskovsky trakt, 2, Tomsk, 634055, Russian Federation; 2-Goldberg Research Institute of Pharmacology and Regenerative Medicine TOMSK NRMC, Lenina Avenue, 3, Tomsk, 634028, Russian Federation; 3-Cardiology Research Institute Tomsk NRMC, A Kievskaya str., 111, Tomsk, 634012, Russian Federation; 4NRC Institute of Immunology FMBA of Russia, Kashirskoye Highway, 24, Moscow, 115522, Russian Federation E-mail: [email protected]

Introduction. For the first time in clinical practice, diagnosis of different stages of lipidemia is conducted according to the level of blood lipids, lipoproteinsand catalase activity. This diagnostic approach can detect early stage of lipidemia against the progression of inflammation and pathogenesis due to the timely appoint a statin therapy, and predict the progress of lipidemia. The research of lipidemia is relevant for the differential diagnosis of coronary atherosclerosis. The aim of the study. At the same time, to study the activity of blood catalase and lipid profile of blood serum with the assessment of dyslipoproteinemia of atherogenic genesis to improve the diagnosis of coronary heart disease (CHD). Methods. Diagnosis of coronary heart disease is verified using clinical and laboratory research methods by using modern equipment. Over 40 male patients with coronary heart disease aged 40–50 years with a history of pathology more than 2 years were examined. The comparison group examined 20 patients with neurocirculatory dystonia (NDC), comparable by sex and age. Statistical data processing was performed using the Statistica 13.0 application software package using student’s T criteria. Results. When analyzing the indicators, the most unfavorable prognosis of the course of coronary atherosclerosis was noted with a high level of lipoprotein-α in the blood against a background of a change in the activity of blood plasma catalase. Conclusion. Biochemical studies of blood lipids revealed a tendency to the development of the initial stage of lipidemia, combined with a slight increase in plasma catalase activity and atherogenic index. Therefore, in clinical practice, the use of kinetic determination of catalase activity is justified to clarify developing lipidemia.
Keywords: 
catalase activity of blood, lipidemia, lipids, lipoproteins

Список литературы: 
  1. Banzaraksheev V.G. Patofiziologicheskoe obosnovanie rezul'tatov modelirovanija aterogennoj dislipidemii u krys. Acta Biomedica Scientifica. 2016; 1 (3–1): 33–6. [Banzaraksheev V.G. Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats. Acta Biomedica Scientifica. 2016; 1 (3–1): 33–6 (in Russian)]
  2. Kornienko E.A., Ojnotkinova O.Sh., Baranov A.P., Goncharova E.I., Ivanov D.V. Sovremennye vzgljady na etiopato- genez infarkta miokarda pri saharnom diabete 2 tipa i metody lechenija (obzor literatury). Vestnik novyh meditsinskih tehnologij. Elektronnoe izdanie. 2015; 2: 3–8. URL: http://www.medtsu.tula.ru/VNMT/ Bulletin/E2015-2/5198.pdf (data obraschenija: 30.06.2015). https://doi.org/10.12737/ 11912. [Kornienko E.A., O’notkinova O.SCH., Baranov A.P., Goncharova E.I., Ivanov D.V. Modern views on the etiopathogenesis of myocardial infraction in diabetes mellitus type 2 and methods of treatment (literature review). Vestnik novyh medicinskih tekhnologij. Elektronnoe izdanie. 2015; 2: 3–8. https://doi.org/10.12737/ 11912 (in Russian)]
  3. Kuznetsov M.R., Virganskij A.O., Kosyh I.V., Jumin S.M., Kunitsyn N.V., Golosnitskij P.Ju., Neshodimov L.A., Magnitskij L.A., Mnatsakanjan G.T., Fukalov A.S. Vozmozhnosti metabolicheskoj terapii pri ateroskleroze. Nevrologicheskij zhurnal. 2014; 19 (4): 56–60. URL: https://cyberleninka.ru/article/n/vozmozhnosti-metabolicheskoy-terapii-pri-ateroskleroze-1. [Kuznetsov M.R., Virganskiy A.O., Kosykh I.V., Yumin S.M., Kunitsyn N.V., Golosnitsiy P. Yu., Neskhodimov L.A., Magnitskiy L.A., Mnatsakanyan G.T., Fukalov A.S. Opportunities of metabolic therapy in atherosclerosis. Nevrologicheskiy zhurnal. 2014; 19 (4): 56–60 (in Russian)]
  4. Tvorogova M.G. Lipidy i lipoproteiny. Laboratornaja diagnostika lipidtransportnoj sistemy. Klinicheskaja laboratornaja diagnostika. 2008; 10: 21–32. [Tvorogova M.G. Lipids and lipoproteins. Laboratory diagnosis of disorders of the lipid transport system. Klinicheskaya laboratornaya diagnostika. 2008; 10: 21–32 (in Russian)]
  5. Expert Patel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J.A.M.A. 2001; 285: 2486–97.
  6. Tsimikas, S., & Hall, J.L. Lipoprotein (a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease. Journal of the American College of Cardiology. 2012; 60 (8): 716–21. https://doi.org/10.1016/j.jacc.2012.04.038
  7. Hasanov A.H., Bakirov B.A., Davletshin R.A., Sharipova I.A., Kudlaj D.A. Vlijanie endotelial'noj disfunktsii na genderno-sosudistuju i nejrokognitivnuju geterogennost' pri mul'tifokal'nom ateroskleroze u pozhilyh patsientov. Profilakticheskaja meditsina. 2019; 22 (4): 129–37. [Khasanov A.K., Bakirov B.A., Davletshin R.A., Sharipova I. A., Kudlay D.A. The effect of endothelial dysfunction on hereditary vascular and neurocognitive heterogeneity in multifocal atherosclerosis in elderly patients. Profilakticheskaya medicina. 2019; 22 (4): 129–37 (in Russian)]
  8. Hasanov A.H., Bakirov B.A., Davletshin R.A., Nurmuhametova R.A., Kudlaj D.A. Klasternye osobennosti komorbidnyh projavlenij u patsientov srednego vozrasta s mul'tifokal'nym aterosklerozom iz gruppy vysokogo riska sosudistyh oslozhnenij. Kardiologija. 2019; 59 (7): 31–6. [Khasanov A.K., Bakirov B.A., Davletshin R.A., Nurmukhametova R.A., Kudlay D.A. Clinical Features of Comorbid Cluster and Premorbidly Manifestations in Patients with High Vascular Risk in the Middle Age Category with the Presence of Multifocal Atherosclerosis. Kardiologiia. 2019; 59 (7): 31–6. https://doi.org/10.18087/cardio.2019.7.n599 (in Russian)]
  9. Zijaeva Sh.T., Aminov S.D., Karimova G.A., Mirzaahmedova K.T. Antioksidantnaja aktivnost' gipolipidemicheskogo preparata firutas. Vestnik KazNMU. 2014; 5: 183–7. URL: https://cyberleninka.ru/article/n/antioksidantnaya-aktivnost-gipolipidemicheskogo-preparata-firutas. [Ziyaeva Sh.T., Aminov S.D., Karimova G.A., Mirzaahmedova K.T. Antioxidant activity of the lipid-lowering drug Firutas. Vestnik. KAZNMU. 2014; 5: 183–7 (in Russian)]
  10. Kolesnikova L.I., Darenskaja M.A., Kolesnikov S.I. Svobodnoradikal'noe okislenie: vzgljad patofiziologa. Bjulleten' sibirskoj meditsiny. 2017; 16 (4): 16–29. [Kolesnikova L.I., Darenskaya M.A., Kolesnikov S.I. Free radical oxidation: a pathophysiologist’s view. Bulletin of Siberian Medicine. 2017; 16 (4): 16–29 https://doi.org/10.20538/1682-0363-2017-4-16-29 (in Russian)]
  11. Klimov A.N., Nikul'cheva N.G. Lipidy, lipoproteiny i ateroskleroz. Piter press, 1995; 98–102. [Klimov A.N., Nikulcheva N.G. Lipids, lipoproteins and atherosclerosis. Piter press, 1995; 98–102 (in Russian)]
  12. Mamaev A.N., Kudlaj D.A. Vizualizatsija dannyh v prezentatsijah, otchetah i issledovanijah. M.: Prakticheskaja meditsina, 2011; 39. [Mamaev A.N., Kudlay D.A. Data visualization in presentations, reports and studies. Prakticheskaya medicina, 2011; 39 (in Russian)]
  13. Nordestgaard B.G., Chapman M.J., Ray K., Borén J., Andreotti F., Watts G.F., Tybjærg-Hansen A. Lipoprotein(a) as a cardiovascular risk factor: current status. European Heart J. 2010; 31 (23): 2844–53. https://doi.org 10.1093/eurheartj/ehq386
  14. Gofman E.A., Martsevich S.Y., Deev A.D., Malysheva A.M., Polyanskaya Y.N., Tolpygina S.N., Mazaev V.P. FIRST RESULTS OF CHD PROGNOSIS STUDY. The Clinician. 2012; 6 (1): 56–62. https://doi.org/10.17650/1818-8338-2012-1-56-62